Objective. Dialysis is the most common renal replacement therapy for patients with end stage renal disease. This paper considers survival of dialysis patients, aiming to assess quality of renal replacement therapy at dialysis centers in Rio de Janeiro, Brazil, and to investigate differences in survival between health facilities.
End stage renal disease (ESDR) is highly prevalent worldwide,
The mortality of patients undergoing dialysis is a main primary outcome variable. It can vary according to treatment with around 1 million patients undergoing renal replacement therapies. Dialysis is still the most common treatment, partly and individual patient characteristics, and between health facilities [2] . Some characteristics of health facilities, such as due to insufficient kidney donation to meet the demand for renal transplants. The mortality rate is one of the most the size of the unit or the number of patients assisted, can affect the outcome [3, 4] . Recommended procedures in important outcome measures and is greatly influenced by individual risk factors such as the type of disease causing hemodialysis, related to adequacy of water sources and filtering, infection control, and handling of hepatitis B serum-ESDR, age, and comorbidities. The use of registry data to analyze patterns and outcome of care of ESDR in order to positive patients, should be routinely assessed. Socioeconomic and cultural profiles may also impact strongly on survival improve quality of dialysis facilities is stimulated through the International Federation of Renal Registries [1] . As there is due to differences in coping with treatment and side effects.
Other known factors related to outcome are nutritional status no 'best' treatment suited for all patients, and improvement in medical technology is a continuous process, the de- [5] , dialysis dose [6] , late nephrology referral [7] , and the use of auxiliary medicine. velopment of methods to be used for quality assessment based on medical registries is of major concern.
In Brazil, more than 95% of renal replacement therapies are funded and controlled by the public health system (SUS). was studied, as alternative treatments are rarely used in Brazil. Payment for services delivered to patients is based on a The data set includes 11 579 patients, receiving hemodialysis computerized information system that collects data on all in 67 DCs. During the follow-up period, 2550 patients procedures on every patient on a monthly basis. Most ESDR changed their place of treatment. Some patients were lost to patients undergo hemodialysis, with <10% undergoing peri-follow-up before the closing date of the study. The reasons toneal dialysis. This choice is possibly related to local medical for this additional censoring of some survival times were culture, as there is no evidence of impact on survival of moving to another state or abandoning treatment (10%), either treatment [8] . The patient is allocated to a specific kidney transplant (9%), and change to peritoneal dialysis dialysis center (DC) for a variety of reasons. Proximity to (2.5%). residence is more important where there is only one DC in The outcome is the time in months since the beginning the same municipality or health district, but irrelevant in of hemodialysis until death or the end of follow-up. Individual larger cities with more than one DC. Place of previous variables included in final model were: (1) age of patient at treatment of underlying disease can influence the choice of onset of disease, as a continuous variable in models; cat-DC. Physicians' suggestions and individual choices are taken egorized in three groups (Ζ42, between 43 and 56, [57) into account, as long as the desired center can accept the in Kaplan-Meier plots; and (2) underlying disease, registered patient. As all DCs are at least partially public funded, in the system using the 10th revision of the International they should all have roughly the same resources, including Classification of Diseases, and categorized as hypertension, solutions, medicines, and equipment. The use of auxiliary diabetes, primary kidney diseases, birth defects, or other medicines and surgical interventions related to ESRD is causes. Hypertension was taken as baseline. standardized [9] . Data on renal replacement therapies available Gender was not included in the study described here, as through this information system have not yet been used for in the preliminary analysis of the data it was found not to evaluation of quality of care delivered. Recently, the Brazilian affect survival. There is no comorbidity, socioeconomic, or Health Ministry released a computer system specifically de-disease severity information in the data set. signed to be used by local level health managers to analyze DC characteristics available were: basic data on high cost ambulatory procedures. However, for • number of dialysis machines, grouped in three classes: (1) a more careful analysis of the outcome, more sophisticated from three to 10; (2) between 11 and 19; and (3) [20, tools must be used [10] . Differences between treatment up to 50 dialysis machines in the DC; and centers certainly play a role in dialysis adequacy [6, 11] . Vari-• other dialysis modalities offered by the units: 23 DCs ation often cannot be fully explained by differences in reoffer both ambulatory peritoneal dialysis (APD) and cyclic gistered clinical procedures, observed patient profile, or other peritoneal dialysis (CPD), 12 offer APD only, five offer specific and known conditions. Hence, a shared frailty or CPD only, and 27 offer no alternative treatment. Note random effect approach to investigating between-center varithat this variable measures other possibilities of treatment ation after allowance for measurable risk factors is proposed.
offered by the unit, but not the actual individual treatment. The frailty model used in this paper is an extension of the Cox If the unit offers peritoneal dialysis, patients can change proportional hazards model, which allows for independent from peritoneal dialysis to hemodialysis, and vice-versa. random effects, one for each DC, as a way of modeling Alternative treatments in the same unit can then be a unobserved sources of variation in survival of patients sharing reason for increasing censoring, as the follow-up stops the same hemodialysis facilities. The use of random effects when patients change treatment. For reference, change modeling in epidemiology has increased in recent years [12] , from peritoneal dialysis to hemodialysis is much more although the introduction of such modeling into eventcommon than change in the other direction [8] . time analysis has proceeded more slowly. This approach to
Other variables investigated, but not included in the final investigation of outcome related to the use of health services model as they showed no relation with survival time, were: can help uncover aspects not yet studied and help formulate total number of rooms, type of machine and type of water health policy guidelines.
filters used, hierarchical level of the DC in the state health system, and presence of separated rooms for hepatitis Bpositive patients. Variables related to the patient profile within DCs, such as proportions of diabetic patients and proportions
Methods
of patients in a queue for kidney transplantation, showed no significant contributions to the model. There were no Data detectable interactions between age and the other covariates. Data on patients using all DCs in Rio de Janeiro State were obtained from the High Complexity Procedures Information Method System (APAC), on CD-ROM. This follow-up system began The basic method, Cox proportional hazards model [13] , is in January 1998, recovering information on all patients using defined as a semi-parametric model because a parametric hemodialysis at that time, including the date treatment began.
form is assumed for the covariate effects, whilst the baseline There is no information on patients that died before this hazard function is treated non-parametrically. It is also called date. The period covered by this study includes all patients on hemodialysis until August 2001. Only hemodialysis survival a proportional hazards model because the ratio of hazard rates of any two individuals is proportional and constant over Formalizing the frailty model, usually assumed to be an time. The assumption of constant relative risk over time was extension of the Cox proportional hazards model, let z be a checked using Schoenfeld's residual analysis [14] .
random variable representing an unknown random effect, The data set comprises a combination of two types of related to dialysis center, with unit mean and variance . data: 'incident', for patients beginning treatment after January Large values of reflect a greater degree of heterogeneity 1998, and 'prevalent' for patients undergoing treatment at among DCs. For an individual with regressor variables vector that time. A further complication is that some patients (x) and frailty effect (z), the form often assumed for the hazard changed DC during their course of treatment. Fortunately, rate is 0 (t/z) = z 0 (t) exp( x). The standard assumption is both of these analytical difficulties can be overcome using a that individuals within each cluster share a common frailty Cox proportional hazards analysis with proper regard to risk effect, z, in our case the clusters being the DCs. set definition, using procedures available in the public domain Individuals or groups with frailty values >1 tend to exstatistical package R [15] .
perience the event at a faster rate than under the basic Cox Let (t/x) be the hazard rate at time t for an individual model, indicating poor performance. Conversely, when frailty with covariate vector x. The Cox model (t/z) = 0 (t) exp( x), values are <1, survival times tend to be longer. Note that where 0 (t) is an arbitrary baseline hazard rate, is a when the variance of z approaches zero, the model reduces parameter vector, and, thus, the logarithm of (t/x)/ 0 (t) is to the basic Cox model. The most common model proposed in the spirit of the usual linear models formulation for the in the literature for the frailty effect is the one-parameter effects of covariates. The model compares the time until gamma distribution [16] . One attractive feature of the gamma death or censoring of each subject with an 'at risk' population distribution is that it is mathematically tractable. Comunder observation with the same survival time. The function putationally, frailties can be viewed as an unobserved coexp( x) for the failure is then compared with corresponding variate, estimated through the estimation-maximization values for patients in the risk set. This makes it easy to deal algorithm [17] . An alternative approach, which is less comwith time-dependent covariates such as DC in use: we simply putationally demanding, is to treat the frailty model as a allocate the patients in the risk set to the DC in use at the penalized Cox model [18] . This algorithm is available in the time of interest. In effect, this divides the total time until death public domain statistical package R, which was used for the or follow-up for each patient into a number of subintervals, analysis. corresponding to periods at risk in the different DCs, ending with induced censoring when the patient changes DC, except of course for the very last interval which may be terminated
Results
by death. The same basic idea of risk set adjustment is used to handle the prevalent part of the data set. Each patient in Kaplan-Meier plots illustrating the effect of each variable are this cohort is included in risk sets only for failure times that shown in Figure 1 , with group definitions and number of are longer than the period between the beginning of their observations given in the legend. Log-rank tests for survival treatment and January 1998. This then properly accounts for differences were all highly significant (P < 10
), due in a large these patients not being at risk of 'observed' failure during part to the size of the data set. The main known risk factor the pre-January 1998 period. Note that failure to adjust for for survival in ESRD patients is diabetes, as can be seen from the prevalent cohort data would lead to an upward bias in the first plot. Age is important too, with a poorer prognosis survival rates, as high-risk patients with early failure would for older patients. The DC variables show a protective effect be under-represented in the data. As mentioned, this adof larger units, although we of course recall that this variable justment is incorporated in the R routine.
is to be considered as a proxy for the likely expertise available One possibility for analyzing the effect of the health facility in the DC; simply adding machinery/equipment would not in is to include it as a dummy variable, estimating the effect of itself affect prognosis. Hemodialysis survival is lower in the each one compared with some chosen baseline unit. This centers that offer only cyclic peritoneal dialysis as an alternative approach, although feasible for a small number of groups, treatment. However, only five of the 67 DCs fall into this does not allow estimation of the parameters of unit level category, with 1139 patients (out of 11 579 in total), and so covariates, as they are the same for all patients in each health this result should be interpreted with caution. unit. Hence, either the effect of covariates can be estimated Table 1 shows the relative risk for each covariate in survival or a single center-specific effect parameter can be estimated, models with and without frailty. Age at onset of disease is but not both simultaneously. An alternative approach, which highly significant: each additional year leads to an increase in allows for unit level covariates in addition to unit level effects, risk of 3%. As expected, diabetes is the most serious underis the so-called random effects model. These models provide lying disease, increasing risk by >50% in comparison with a flexible and powerful tool for the analysis of grouped data, hypertension. Birth defect causes for kidney failure present which can be useful in describing heterogeneity and/or the best prognosis, as in this group the chances for kidney correlation among individuals. In the survival analysis context, transplant are greater. Primary kidney disease does not affect random effects are assumed to act multiplicatively on the survival. Under the label of 'other causes', a number of baseline hazard. This random effect can be thought of as a different pathologies, from cancer to autoimmune diseases, 'frailty', increasing group or individual susceptibility to death when it is large, and decreasing susceptibility when it is small. which are all too rare to be analyzed individually, were grouped. Parameter estimates of individual covariates are of the random effect broadens the confidence intervals, and three DC level covariates lost significance. quite similar for both models.
The estimated frailty variance (0.43) is significant and With respect to DC covariates, the unit size showed a indicates the presence of a large variability among DCs. The strong protective effect, with a consistent trend: large units relative risks of units estimated through the frailty effect (10-19 machines) present a slightly smaller risk, while those varied from 0.235 and 3.146, with four DCs with less than with >20 machines show a reduction of 40%. Providing half the relative risk and two units with more than double cyclic peritoneal dialysis as an alternative treatment showed the risk (Figure 2 ). Based on the confidence interval of the highest risk. Patients receiving hemodialysis in one of the relative risk of each unit frailty, the DCs were classified into five centers where cyclic dialysis was the only alternative three groups: frailty significantly above one, frailty significantly treatment had a relative risk that was 2.3 times greater than below one, and the middle risk group. A Kaplan-Meier plot those using DCs where no other treatment was offered.
of these groups ( Figure 3 ) displays risk profiles compatible Offering only ambulatory peritoneal dialysis has also been with estimated frailties. The survival curves of four DCs with found to be a risk factor, although only in the model without the highest risk, together with the mean survival in the frailty effect, while offering both types of hemodialysis pressignificantly high-risk group show that the model is adequately ents a protective effect in the same model. capturing high-risk units. When DC frailties are included in the model there is a significant increase in the marginal likelihood, estimated after integrating out the frailty effect. For just one degree of freedom in the model, the likelihood increased from −26 199.30 to Discussion −25 870.32. The estimated size of the DC covariate coefficients increased under the frailty effect model, as expected theoretically Assessment of outcome in any high technology medical treatment, such as renal replacement therapy, is extremely [19] , but only by a small amount. At the same time the inclusion ..................................................................................................................................................................................................................... important in order to maintain quality of care. Furthermore, The protective effect of larger DCs found in other studies [3, 20] should be investigated in detail, as after controlling for it allows estimation of the impact of new therapies and technology introduced in uncontrolled, normal-use con-the main covariates (age and underlying disease), larger units still had a reduced risk of approximately 40%. There was no ditions. For this task, the data sets have to be the routine ones, with all concomitant problems. Exploratory data analysis evidence of patient profiles at DCs affecting survival.
It was not possible to compare our results related to the suggested that the quality of the information set was adequate for the purpose of this study. Moreover, data are updated on offer of dialysis modalities, because most DCs worldwide offer both kinds of dialysis. As only hemodialysis patients a monthly basis and are made available for analysis within 3 months, thus allowing regular and up-to-date assessment.
were included in the study, and follow-up starts with the actual beginning of hemodialysis, not with ESRD diagnosis, Many variables included in the system, however, did not seem to be associated with patient survival. For instance, all patients undergoing CPD may have moved from this therapy to hemodialysis, and thus had prolonged ESRD. This longer variables related to the DC, with respect to equipment, physical installations, and filters, showed no relation to sur-time of disease could affect observed survival during hemodialysis. However, this would also happen with ambulatory vival. Although this kind of information is useful at the time of the implementation of routines, collecting the same data peritoneal dialysis and the offer of this modality in the DC did not affect survival as strongly, since this covariate lost on unit structure every month may be inefficient. On the other hand, the system should be sufficiently flexible to significance in the frailty model. Moreover, CPD is not a first choice for treatment, and is used only when patients include new variables as soon as they are implemented in any service, allowing follow up of any subsequent changes cannot undergo hemodialysis (usually three times a week) or cannot be trained to use peritoneal dialysis at home. CPD in patient survival.
The individual variables included in the model behaved as may also be a temporary resource when arterial fistula access is lost. Centers offering only CPD, and not APD, may be expected. Other important factors not available, however, are the nutritional status at the beginning of dialysis [5] and the technologically impaired. A longer follow-up time is needed to evaluate this finding, as peritoneal dialysis is still little used socioeconomic status of the patient. The latter could help to estimate problems in coping with the renal replacement in Rio: in the last month of the follow-up period, only 6% of patients were undergoing PD. However, these findings therapy.
One important methodological issue tackled in this paper have to be seen in the context of assessing survival, quality of life, and global costs of both treatments. It should be is the simultaneous use of prevalent and incident data, which is normal in observational studies. The technique to deal with noted that the choice of treatment modality is strongly influenced by the provider's perspective, such as whether it was easily implemented using R, as well as the use of a time-dependent covariate.
they choose high cost investments in expensive hemodialysis facilities as opposed to low fixed costs and high expenditures model the influence of each DC in risk, through including a dummy variable for it in the model, does not allow us to in peritoneal dialysis supplies [21] .
The frailty model allowed identification of variation in risk include in the model unit level covariates, as they are the same for all patients in the DC. So if DC relative risk was not attributable to any measured covariates, and showed a large amount of variability between DCs with respect to estimated in this way we could not at the same time determine the effect of variables such as unit size or other treatments performance. One possible explanation for this variability could be attributed to differences in the socioeconomic level offered.
The focus of this study is specifically hemodialysis patients, of the population using different services, due to location. As there is no variable for measuring socioeconomic status, because peritoneal dialysis therapies, though beginning to be used more widely throughout the state, are still little used in a possible way to incorporate this could be through the investigation of a geographical pattern in the frailty of DCs the region. However, as the information system contains all data on the trajectory of each patient, including changes of [22] . Preliminary analysis showed no visible pattern, although more investigation is needed.
residence, unit, therapies, and related surgical interventions, it will be possible to devise a comprehensive regular assessOther possible explanations for significant variation in DC survival rates are in different patient mix or unregistered ment of high cost ambulatory therapies. Studying this kind of longitudinal data, in spite of methodological problems, differences in care practices. The first one could be explored in a model still under development, including individual frailty would allow better understanding of the entire process.
Although there is no doubt that controlled clinical trials besides the aggregated level one. The variations in care have to be investigated locally in order to uncover possible represent the gold standard with which to assess efficacy of any treatment under everyday conditions, in the prolonged differences and to propose new variables to capture these differences. This is one important advantage of the frailty treatment of a chronic disease, the use of registry data is critical in comparing different centers, patients, and places. model used here: detecting unmeasured variation leading to differences in risk among units. The other possible way to The frailty model proposed in this paper can be useful for 
